Converting Enzyme Inhibitor or AT 1 -Receptor Blocker for Decreasing Long-Term Mortality in Patients With Stroke History and Renal Dysfunction?
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details